3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Recurrence
3
Neoplasm Metastasis
3
Melanoma
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Cutaneous Squamous Cell Carcinoma
2
Carcinoma, Basal Cell
2
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Ovarian Neoplasms
1
Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Head and Neck Neoplasms
1
Glioma
1
Glioblastoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Advanced Non-Small Cell Lung Carcinoma
1
Adenocarcinoma
1
Interventions
Cisplatin
13
Radiotherapy, Intensity-Modulated
11
Radiotherapy
5
Carboplatin
5
Radiation
4
Cetuximab
4
durvalumab
3
Platinum
3
Nivolumab
3
1,2-diaminocyclohexaneplatinum II citrate
3
pembrolizumab
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Specimen Handling
2
Restraint, Physical
2
Paclitaxel
2
Fluorodeoxyglucose F18
2
Cyclophosphamide
2
Bupropion
2
Biopsy
2
Acupuncture Therapy
2
veliparib
1
utomilumab
1
sodium thiosulfate
1
ficlatuzumab
1
dehydroftorafur
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Oropharyngeal Neoplasms
×
cemiplimab
×
Clear all
No trials found.